Answers are grounded in this paper and cite their sources.
Blood urea nitrogen (BUN) is a routinely available biomarker influenced by renal perfusion, volume status, neurohormonal activation, and catabolic state. Evidence relating admission BUN to short-term outcomes in acute pulmonary embolism (PE) may be affected by disease severity and comorbidity. We evaluated the association between admission BUN and in-hospital all-cause mortality in adults with acute PE. Among 798 adults admitted with confirmed acute PE during January 2023–November 2024, 767 had admission BUN measurements. Incomplete variables in the descriptive tables and regression were multiply imputed using R mice (50 datasets, 20 iterations); BUN and mortality were not imputed. Logistic estimates were pooled using Rubin’s rules; Model 3 adjusted for age, sex, diabetes and central PE. Complete-case and ridge-penalized analyses assessed sensitivity. A restricted cubic spline explored functional form. A separate analysis reproduced the original 20% missingness screening rule, retaining 657 patients. The median age was 75.0 years, 50.6% were men, and 21 patients died in hospital (2.74%). Mortality was 1.16%, 2.37% and 4.69% across increasing BUN tertiles. Per 1-mmol/L increase in BUN, pooled Model 3 gave OR 1.090, 95% CI 1.019–1.165; P = 0.012 ( n = 767). The complete-case estimate was similar (OR 1.091, 95% CI 1.020–1.167; P = 0.011; n = 766), whereas the complete-case ridge estimate was attenuated (OR 1.052, 95% CI 0.995–1.113; P = 0.075). The 657-patient sensitivity analysis gave a directionally consistent pooled estimate (OR 1.128, 95% CI 1.045–1.218; P = 0.002). The pooled spline showed an overall association ( P = 0.040) without evidence of non-linearity ( P = 0.261). Higher admission BUN was associated with in-hospital mortality in this single-center PE cohort. Results were directionally consistent in the 657-patient cohort-selection sensitivity analysis. However, the small number of deaths, attenuation in the ridge-penalized sensitivity analysis of the primary cohort, and absence of standardized PE severity variables limit causal and predictive interpretation. BUN should be regarded as a potential complementary marker requiring external validation, not as a standalone or proven incremental prognostic tool.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: